Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Satveer K. Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 1, pp. e42-e52
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Brian MacKenna, Nicholas A. Kennedy, Amir Mehrkar, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 7, pp. e490-e506
Open Access | Times Cited: 92
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek Abhishek, Rosemary J. Boyton, Nicholas Peckham, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 840-850
Open Access | Times Cited: 70
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Matthijs Oyaert, Marie‐Angélique De Scheerder, Sophie Van Herrewege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review
Po‐Chien Wu, I‐Hsin Huang, Chuang‐Wei Wang, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 6, pp. 775-799
Open Access | Times Cited: 48
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
Roya Monica Dayam, Jaclyn C. Law, Rogier Goetgebuer, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 44
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study
Madhumita Shrotri, Ellen Fragaszy, Vincent Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study
Emmanouil Karampinis, George Goudouras, Niki Ntavari, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 15
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis
Pedro Martínez‐Fleta, Esther F. Vicente‐Rabaneda, Ana Triguero‐Martínez, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review
Beatriz Garcillán, Miguel Salavert, José R. Regueiro, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 297-297
Open Access | Times Cited: 20
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
Maria De Santis, Francesca Motta, Natasa Isailovic, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 801-801
Open Access | Times Cited: 19
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy
Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients
Zoltán Szekanecz, Attila Balog, Tamás Constantin, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Open Access | Times Cited: 16
Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
Martin Feuchtenberger, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology International (2022) Vol. 42, Iss. 6, pp. 959-966
Open Access | Times Cited: 16
Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis
Rossella Talotta
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 9
Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide.
Ryan Fan, Jeffrey M. Cohen
PubMed (2022) Vol. 95, Iss. 2, pp. 249-255
Closed Access | Times Cited: 14
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis
Sonphet Chirasuthat, Yanisa Ratanapokasatit, Kunlawat Thadanipon, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40009-adv40009
Open Access | Times Cited: 2
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Ioana Andreica, Arturo Blázquez-Navarro, Jan Sokolar, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002293-e002293
Open Access | Times Cited: 13
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 10, pp. e1010882-e1010882
Open Access | Times Cited: 13
Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
Jitka Smetanová, Zuzana Střížová, Anna Šedivá, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 3, pp. e163-e166
Open Access | Times Cited: 16
Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?
Maurizio Benucci, Arianna Damiani, María Infantino, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2089-2096
Open Access | Times Cited: 11
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
Dario Graceffa, Francesca Sperati, Claudio Bonifati, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top